27100441 Visualization
Back to Main Page
The institutional review board (Chengdu Military General Hospital) approved this work and waived the need for informed consent.In
2013
Date
, a
66
Age
-
year
Age
-
old
Age
farmer
Occupation
with a history of
ventricular
History
tachycardia
History
(VT)
History
and
hypertension
History
presented
Clinical_event
to the
Emergency
Nonbiological_location
Department
Nonbiological_location
with
continuous
Detailed_description
palpitation
Sign_symptom
,
chest
Sign_symptom
tightness
Sign_symptom
,
profuse
Severity
sweating
Sign_symptom
and
nausea
Sign_symptom
with no obvious predisposing
causes
Disease_disorder
.The patient experienced a
sudden
Lab_value
drop
Lab_value
in
blood
Diagnostic_procedure
pressure
Diagnostic_procedure
and
acute
Detailed_description
confusion
Sign_symptom
.After an
immediate
Detailed_description
electrical
Therapeutic_procedure
conversion
Therapeutic_procedure
, his
consciousness
Sign_symptom
was gradually restored, and
symptoms
Sign_symptom
relieved.Then, this patient was
transferred
Clinical_event
to the
Department
Nonbiological_location
of
Nonbiological_location
Cardiology
Nonbiological_location
for further
evaluations
Diagnostic_procedure
and
treatments
Therapeutic_procedure
.The patient's
blood
Diagnostic_procedure
pressure
Diagnostic_procedure
was
105/75
Lab_value
mm
Lab_value
Hg
Lab_value
upon admission, with a
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
75
Lab_value
beats/min
Lab_value
,
body
Diagnostic_procedure
temperature
Diagnostic_procedure
of
36.6°C
Lab_value
and
respiration
Diagnostic_procedure
rate
Diagnostic_procedure
of
18
Lab_value
times/min
Lab_value
.The
heart
Biological_structure
border
Biological_structure
extended
Sign_symptom
to
Lab_value
the
Lab_value
left
Lab_value
, with the
apical
Diagnostic_procedure
impulse
Diagnostic_procedure
located in the
left
Lab_value
5th
Lab_value
intercostal
Lab_value
space
Lab_value
,
1.0
Distance
cm
Distance
lateral
Distance
to
Distance
the
Distance
midclavicular
Distance
line
Distance
.The patient had a history of
hypertension
Disease_disorder
over
History
30
Duration
years
Duration
without
History
regular
History
antihypertensive
History
medication
History
.The
highest
Detailed_description
blood
Diagnostic_procedure
pressure
Diagnostic_procedure
was
170/110
Lab_value
mm
Lab_value
Hg
Lab_value
.There was
no
Family_history
family
Family_history
history
Family_history
of
Family_history
early
Family_history
coronary
Family_history
artery
Family_history
disease
Family_history
or
Family_history
sudden
Family_history
cardiac
Family_history
death
Family_history
.He
did
History
not
History
smoke
Activity
cigarettes
Activity
or
History
use
Activity
illicit
Activity
drugs
Activity
,
and
History
rarely
History
consumed
Activity
alcohol
Activity
.He also reported
no
History
known
History
contacts
History
with
History
sick
History
persons
History
and
History
no
History
recent
History
travel
History
.
Twelve
Detailed_description
-
lead
Detailed_description
surface
Detailed_description
electrocardiogram
Diagnostic_procedure
(
ECG
Diagnostic_procedure
) of
VT
Disease_disorder
indicated that the origin of VT was at the
boundary
Biological_structure
between
Biological_structure
right
Biological_structure
ventricular
Biological_structure
outflow
Biological_structure
tract
Biological_structure
(
RVOT
Biological_structure
) and
tricuspid
Biological_structure
valve
Biological_structure
.When
VT
Disease_disorder
increased
Lab_value
to
150
Lab_value
beats/min
Lab_value
or
Lab_value
higher
Lab_value
, no
epsilon
Sign_symptom
waves
Sign_symptom
were found in the
precordial
Diagnostic_procedure
leads
Diagnostic_procedure
(Figure1A and B).In contrast, when
VT
Disease_disorder
decreased
Lab_value
to
120
Lab_value
beats/min
Lab_value
or
Lab_value
lower
Lab_value
,
epsilon
Sign_symptom
waves
Sign_symptom
appeared in
leads
Diagnostic_procedure
V1
Diagnostic_procedure
–
V2
Diagnostic_procedure
(Figure1C).Notably, the
epsilon
Sign_symptom
waves
Sign_symptom
preceded
Lab_value
QRS
Lab_value
waves
Lab_value
in
leads
Diagnostic_procedure
V1
Diagnostic_procedure
–
V2
Diagnostic_procedure
, while
endocardiac
Diagnostic_procedure
tracing
Diagnostic_procedure
confirmed that the corresponding
local
Lab_value
potential
Lab_value
originating from
RVOT
Biological_structure
appeared
prior
Detailed_description
to
Detailed_description
the
Detailed_description
ventricular
Detailed_description
rhythm
Detailed_description
(Figure (Figure1D).1D).
Sinus
Detailed_description
ECG
Diagnostic_procedure
in the
year
Date
of
Date
2013
Date
suggested a
slight
Lab_value
left
Lab_value
deviation
Lab_value
of
electric
Diagnostic_procedure
axis
Diagnostic_procedure
, with a
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
87
Lab_value
beats/min
Lab_value
and
flat
Lab_value
T
Lab_value
waves
Lab_value
in
lead
Diagnostic_procedure
II
Diagnostic_procedure
.
T
Sign_symptom
wave
Sign_symptom
inversions
Sign_symptom
were found in
leads
Diagnostic_procedure
III,
Diagnostic_procedure
avF
Diagnostic_procedure
and
Diagnostic_procedure
V1
Diagnostic_procedure
–
V3
Diagnostic_procedure
, meanwhile
epsilon
Sign_symptom
waves
Sign_symptom
were found
following
Lab_value
QRS
Lab_value
complex
Lab_value
in
leads
Diagnostic_procedure
V1
Diagnostic_procedure
–
V3
Diagnostic_procedure
(Figure (Figure2B).2B).When the
lead
Diagnostic_procedure
avR
Diagnostic_procedure
was
amplified
Detailed_description
,
epsilon
Sign_symptom
waves
Sign_symptom
were also found
behind
Lab_value
QRS
Lab_value
waves
Lab_value
(Figure 2C).
Atrial
Biological_structure
premature
Sign_symptom
beats
Sign_symptom
appeared
occasionally
Frequency
.Moreover,
ventricular
Biological_structure
premature
Sign_symptom
beats
Sign_symptom
were also found to originate from the
right
Biological_structure
ventricular
Biological_structure
apex
Biological_structure
, with
epsilon
Sign_symptom
waves
Sign_symptom
appearing
behind
Lab_value
QRS
Lab_value
waves
Lab_value
(Figure (Figure2B).2B).In contrast,
sinus
Biological_structure
ECG
Diagnostic_procedure
obtained in the
year
Date
of
Date
1999
Date
revealed similar
left
Lab_value
deviation
Lab_value
of
electric
Diagnostic_procedure
axis
Diagnostic_procedure
,
flat
Sign_symptom
T
Sign_symptom
waves
Sign_symptom
and
T
Sign_symptom
wave
Sign_symptom
inversions
Sign_symptom
, but absence of
epsilon
Sign_symptom
waves
Sign_symptom
(Figure (Figure2A).2A).Data from
biochemical
Diagnostic_procedure
assays
Diagnostic_procedure
were as follows:
cardiac
Diagnostic_procedure
troponin
Diagnostic_procedure
I
Diagnostic_procedure
level was
0.714
Lab_value
μg/L
Lab_value
(normal range, 0–0.06 μg/L),
serum
Diagnostic_procedure
B
Diagnostic_procedure
-
type
Diagnostic_procedure
natriuretic
Diagnostic_procedure
peptide
Diagnostic_procedure
level was
466.530
Lab_value
pg/mL
Lab_value
(normal range, 0–100 pg/mL),
serum
Diagnostic_procedure
d
Diagnostic_procedure
-
dimer
Diagnostic_procedure
level was
8.14
Lab_value
mg/L
Lab_value
(normal range, 0–0.55 mg/L),
blood
Diagnostic_procedure
urea
Diagnostic_procedure
level was
11.69
Lab_value
mmol/L
Lab_value
(normal range, 2.90–7.20 mmol/L),
serum
Diagnostic_procedure
creatinine
Diagnostic_procedure
level was
144.00
Lab_value
μmol/L
Lab_value
(normal range, 44–133 μmol/L),
serum
Diagnostic_procedure
uric
Diagnostic_procedure
acid
Diagnostic_procedure
level was
611.40
Lab_value
μmol/L
Lab_value
(normal range, 100–432 μmol/L), and
endogenous
Diagnostic_procedure
creatinine
Diagnostic_procedure
clearing
Diagnostic_procedure
value was
57.90
Lab_value
mL/min
Lab_value
(normal range, >80 mL/min).
Echo
Diagnostic_procedure
data revealed
remarkably
Severity
enlarged
Sign_symptom
right
Biological_structure
atrium
Biological_structure
and
right
Biological_structure
ventricle
Biological_structure
, and
widened
Sign_symptom
ROVT
Biological_structure
.
Uncoordinated
Sign_symptom
motions
Sign_symptom
of the
left
Biological_structure
and
Biological_structure
right
Biological_structure
ventricular
Biological_structure
walls
Biological_structure
were also detected.Moreover, we also found
aortic
Biological_structure
valve
Biological_structure
degradation
Sign_symptom
with
slight
Severity
regurgitation
Sign_symptom
,
slight
Severity
mitral
Biological_structure
regurgitation
Sign_symptom
, and
moderate
Severity
to
Severity
severe
Severity
tricuspid
Biological_structure
regurgitation
Sign_symptom
.The
left
Diagnostic_procedure
ventricular
Diagnostic_procedure
diastolic
Diagnostic_procedure
function
Diagnostic_procedure
was
reduced
Lab_value
to
55%
Lab_value
(Figure 3A and B).The
coronary
Diagnostic_procedure
angiogram
Diagnostic_procedure
revealed no
vascular
Disease_disorder
stenosis
Disease_disorder
(Figure 3C–E).Based on the above-mentioned examinations, this patient met at least 2 major criteria, the bilateral ventricular dilation and the existence of epsilon waves, providing diagnostic support for
ARVC
Disease_disorder
.A
diet
Therapeutic_procedure
with
low
Detailed_description
salt
Detailed_description
and
low
Detailed_description
fat
Detailed_description
was suggested.The patient was also treated with
metoprolol
Medication
succinate
Medication
sustained
Administration
-
release
Administration
tablets
Administration
(
23.75
Dosage
mg
Dosage
daily
Dosage
,
p.o
Administration
.),
amiodarone
Medication
(
200
Dosage
mg
Dosage
daily
Dosage
,
p.o.
Administration
),
furosemide
Medication
(
20
Dosage
mg
Dosage
daily
Dosage
,
i.v.
Administration
), and
compound
Detailed_description
α
Medication
-
ketoacid
Medication
tablets
Administration
(
2.52
Dosage
g
Dosage
daily
Dosage
,
p.o.
Administration
).Moreover, VTs with
different
Detailed_description
morphologies
Detailed_description
and
Detailed_description
cycle
Detailed_description
lengths
Detailed_description
were found during
radiofrequency
Therapeutic_procedure
ablation
Therapeutic_procedure
(Figure 4).The
substrate
Diagnostic_procedure
voltage
Diagnostic_procedure
mapping
Diagnostic_procedure
revealed that the
anterior
Biological_structure
wall
Biological_structure
of
Biological_structure
RVOT
Biological_structure
was wrapped by
circular
Shape
scar
Sign_symptom
(Figure 5A).Considering the association of VT with scar areas,
substrate
Therapeutic_procedure
ablation
Therapeutic_procedure
was chosen for this patient.The residual potentials in the scar areas were searched, and then
linear
Detailed_description
and
focal
Detailed_description
ablations
Therapeutic_procedure
were performed (Figure 5B).Neither
programmed
Detailed_description
stimulation
Diagnostic_procedure
nor
induced
Detailed_description
stimulation
Diagnostic_procedure
could induce
VT
Disease_disorder
after the procedure was completed, indicating the success of operation.The
ECG
Diagnostic_procedure
after radiofrequency ablation showed
sinus
Sign_symptom
rhythm
Sign_symptom
, with a
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
61
Lab_value
beats/min
Lab_value
,
T
Sign_symptom
wave
Sign_symptom
inversions
Sign_symptom
in
leads
Diagnostic_procedure
III
Diagnostic_procedure
and
Diagnostic_procedure
avF
Diagnostic_procedure
, and
epsilon
Sign_symptom
waves
Sign_symptom
and
T
Sign_symptom
wave
Sign_symptom
inversions
Sign_symptom
in
leads
Diagnostic_procedure
V1
Diagnostic_procedure
–
V3
Diagnostic_procedure
(Figure 2D).This patient was
discharged
Clinical_event
from
hospital
Nonbiological_location
on
day
Date
9
Date
with a regimen of
metoprolol
Medication
succinate
Medication
sustained
Administration
-
release
Administration
tablets
Administration
(
23.75
Dosage
mg
Dosage
daily
Dosage
,
p.o.
Administration
),
amiodarone
Medication
hydrochloride
Medication
tablets
Administration
(
200
Dosage
mg
Dosage
daily
Dosage
,
p.o.
Administration
),
spironolactone
Medication
tablets
Administration
(
40
Dosage
mg
Dosage
daily
Dosage
,
p.o.
Administration
), and
fosinopril
Medication
sodium
Medication
tablets
Administration
(
10
Dosage
mg
Dosage
daily
Dosage
,
p.o.
Administration
).The patient was
followed
Clinical_event
up
Clinical_event
3
Date
months
Date
after
Date
discharge.He had no recurrent
palpitation
Sign_symptom
,
chest
Biological_structure
tightness
Sign_symptom
,
profuse
Severity
sweating
Sign_symptom
or
nausea
Sign_symptom
.
Although
Other_entity
ARVC
Other_entity
was
Other_entity
the
Other_entity
main
Other_entity
diagnosis
Other_entity
at
Other_entity
the
Other_entity
time
Other_entity
of
Other_entity
this
Other_entity
patient's
Other_entity
initial
Other_entity
presentation,
Other_entity
it
Other_entity
is
Other_entity
essential
Other_entity
in
Other_entity
such
Other_entity
cases
Other_entity
to
Other_entity
perform
Other_entity
a
Other_entity
reassessment
Other_entity
for
Other_entity
the
Other_entity
presence
Other_entity
of
Other_entity
structural
Other_entity
heart
Other_entity
disease,
Other_entity
which
Other_entity
can
Other_entity
evolve
Other_entity
over
Other_entity
time
Other_entity
.